• 1. N-terminal aromatic tag induced self assembly of tryptophan–arginine rich ultra short sequences and their potent antibacterial activity
  Seema Joshi,Rikeshwer P. Dewangan,Mohammad Shahar Yar,Diwan S. Rawat,Santosh Pasha RSC Adv. 2015 5 68610

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Introduction to 2-Fluoro-3-(trifluoromethyl)benzoic acid (CAS No. 115029-22-6)

2-Fluoro-3-(trifluoromethyl)benzoic acid (CAS No. 115029-22-6) is a fluorinated aromatic carboxylic acid that has garnered significant attention in the field of pharmaceutical and agrochemical research due to its unique structural properties and potential biological activities. This compound, characterized by the presence of both fluoro and trifluoromethyl substituents on a benzoic acid backbone, exhibits distinct electronic and steric effects that make it a valuable scaffold for drug discovery and material science applications.

The structural motif of 2-fluoro-3-(trifluoromethyl)benzoic acid consists of a benzene ring substituted at the 2-position with a fluorine atom and at the 3-position with a trifluoromethyl group. The fluoro group introduces a slight electron-withdrawing effect through resonance, while the trifluoromethyl group exerts a stronger electron-withdrawing effect via inductive forces. This combination of substituents enhances the lipophilicity and metabolic stability of the compound, making it an attractive candidate for further derivatization and optimization.

In recent years, the pharmaceutical industry has increasingly focused on fluorinated compounds due to their improved pharmacokinetic profiles, including enhanced bioavailability, reduced metabolic clearance, and increased binding affinity to biological targets. 2-Fluoro-3-(trifluoromethyl)benzoic acid is no exception and has been explored in various therapeutic areas, particularly in oncology and anti-inflammatory drug development.

One of the most compelling aspects of 2-fluoro-3-(trifluoromethyl)benzoic acid is its potential as a precursor in the synthesis of more complex pharmacophores. Researchers have leveraged its reactive sites—specifically the carboxylic acid group and the positions of the fluoro and trifluoromethyl substituents—to develop novel inhibitors targeting enzymes such as kinases and cyclooxygenases. These enzymes are often overexpressed in diseases like cancer and play crucial roles in inflammatory pathways.

Recent studies have highlighted the utility of 2-fluoro-3-(trifluoromethyl)benzoic acid in designing small-molecule inhibitors with improved selectivity and efficacy. For instance, derivatives of this compound have been shown to exhibit potent activity against specific isoforms of tyrosine kinases, which are implicated in tumor growth and progression. The fluorine atom at the 2-position modulates the electronic properties of the molecule, allowing for fine-tuning of binding interactions with protein targets.

The trifluoromethyl group, on the other hand, contributes to steric hindrance and enhances hydrophobic interactions, which are critical for achieving high affinity binding. This dual functionality has been exploited to develop compounds that exhibit better pharmacological properties compared to their non-fluorinated counterparts. The carboxylic acid moiety also provides a handle for further chemical modifications, enabling the synthesis of prodrugs or conjugates that can improve delivery or target specificity.

In agrochemical research, 2-fluoro-3-(trifluoromethyl)benzoic acid has been investigated as a building block for herbicides and fungicides. The presence of fluorine atoms is known to enhance the bioactivity of agrochemicals by improving their resistance to metabolic degradation. By incorporating this compound into larger molecular frameworks, researchers aim to develop next-generation crop protection agents with improved environmental profiles.

The synthesis of 2-fluoro-3-(trifluoromethyl)benzoic acid typically involves multi-step organic transformations starting from commercially available aromatic precursors. Common synthetic routes include halogenation followed by cross-coupling reactions or direct fluorination techniques. The introduction of both fluoro and trifluoromethyl groups requires careful control over reaction conditions to ensure high yields and purity.

Advances in synthetic methodologies have enabled more efficient production methods for fluorinated compounds like 2-fluoro-3-(trifluoromethyl)benzoic acid, making them more accessible for research purposes. Techniques such as palladium-catalyzed cross-coupling reactions have streamlined the introduction of fluorine atoms into complex molecular architectures, reducing both cost and environmental impact.

The growing interest in fluorinated compounds has also spurred innovation in analytical techniques for their characterization. High-resolution mass spectrometry (HRMS), nuclear magnetic resonance (NMR) spectroscopy, and X-ray crystallography are commonly employed to elucidate the structure and purity of these molecules. These tools are essential for ensuring that synthesized compounds meet stringent quality standards before they can be used in preclinical or clinical studies.

From a regulatory perspective, compounds like 2-fluoro-3-(trifluoromethyl)benzoic acid must undergo rigorous testing to assess their safety and efficacy before they can be commercialized. Regulatory agencies require comprehensive data on their toxicological profiles, pharmacokinetic behavior, and potential side effects. This regulatory framework ensures that only compounds with demonstrated therapeutic value reach patients or farmers.

In conclusion,2-fluoro-3-(trifluoromethyl)benzoic acid (CAS No. 115029-22-6) represents a promising compound with diverse applications in pharmaceuticals and agrochemicals. Its unique structural features make it an ideal candidate for further exploration in drug discovery programs aimed at addressing unmet medical needs. As synthetic chemistry continues to evolve, it is likely that derivatives of this compound will play an increasingly important role in developing innovative solutions for health and agriculture.

• 115029-23-7(2-Fluoro-5-(trifluoromethyl)benzoic acid)
• 5216-22-8(2,3,5,6-Tetrafluoro-4-(trifluoromethyl)benzoic Acid)
• 118829-14-4(Benzoic acid,2,4,5-trifluoro-3-(trifluoromethyl)-)
• 157337-81-0(2,4-Difluoro-3-(trifluoromethyl)benzoic Acid)
• 67515-55-3(4-Fluoro-3-(trifluoromethyl)benzoic acid)
• 203915-94-0(Benzoic acid,2,3,4-trifluoro-5-(trifluoromethyl)-)
• 261945-05-5(2,5-Difluoro-4-(trifluoromethyl)benzoic acid)
• 115029-24-8(2-Fluoro-4-(trifluoromethyl)benzoic acid)
• 237424-17-8(2,3-Difluoro-4-(trifluoromethyl)benzoic acid)
• 1048921-49-8(2,6-Difluoro-3-(trifluoromethyl)benzoic acid)